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Master’s Thesis title
Numerical model of microwave heating of different types of tumours.
Abstract
The knowledge of complete temperature distribution throughout heated tissues is cru-
cial in designing efficient hyperthermia treatment for cancer. The cooling effect of large
blood vessels may cause inhomogeneity in temperature distribution and possible under-
dose, which may later lead to tumour re-growth. The aim of this thesis is to create
multiple numerical simulations describing local microwave heating of two different tumour
types based on their blood supply – a tumour, which lies directly on the blood vessel and
a tumour being supplied from its surface. The next aim is to validate correct parameter
settings in the simulations experimentally. In this thesis, numerical models of a tumour
lying on a blood vessel and a tumour being supplied from its surface have been developed
to calculate the temperature distribution in tissue during microwave hyperthermia treat-
ment. Furthermore, a heterogeneous agar model was created and used in an experiment
validating the settings of the numerical simulations. The used thermal model is based
on bioheat transfer equation describing heat transfer in perfused tumour and surrounding
tissue. Equations were solved in COMSOL Multiphysics by finite element method. As re-
sults of the simulations, tumours supplied from their surface are being heated more easily
and complete tumour necrosis can be achieved with hyperthermal treatment. Compared
to that, tumours lying directly on a blood vessel need more output power to be heated to
desired temperatures, which brings higher possibility of surrounding tissue damage.
Keywords
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Na´zev diplomove´ pra´ce
Numericky´ model mikrovlnne´ho ohrˇevu r˚uzny´ch typ˚u na´dor˚u
Abstrakt
Prˇi navrhova´n´ı efektivn´ı onkologicke´ le´cˇby metodou mikrovlnne´ hypertermie je nezbytna´
znalost kompletn´ıho teplotn´ıho rozlozˇen´ı v le´cˇene´ oblasti. Schopnost velky´ch ce´v ochla-
dit okoln´ı tka´nˇ mu˚zˇe ovlivnit teplotn´ı rozlozˇen´ı a zp˚usobit nedostatecˇne´ prohrˇa´t´ı, cozˇ
mu˚zˇe pozdeˇji ve´st ke zpeˇtne´mu dor˚usta´n´ı na´doru. C´ılem te´to pra´ce je vytvorˇit num-
ericke´ simulace popisuj´ıc´ı mikrovlnny´ ohrˇev dvou r˚uzny´ch typ˚u na´dor˚u v za´vislosti na
jejich ce´vn´ım za´soben´ı - na´dor, ktery´m ce´va procha´z´ı, a na´dor, ktery´ je za´sobova´n krv´ı ze
sve´ho povrchu. Da´le je c´ılem experimenta´lneˇ oveˇrˇit spra´vne´ nastaven´ı simulac´ı. V te´to
pra´ci byly vytvorˇeny numericke´ modely na´doru, ktery´m ce´va prˇ´ımo procha´z´ı, a na´doru
za´sobene´ho ze sve´ho povrchu, ktere´ slouzˇ´ı k vy´pocˇtu teplotn´ıho rozlozˇen´ı prˇi le´cˇbeˇ metodou
mikrovlnne´ hypertermie. Da´le byl vytvorˇen heterogenn´ı agarovy´ model tka´neˇ, ktery´ byl
pouzˇit pro experimenta´ln´ı oveˇrˇen´ı nastaven´ı numericky´ch simulac´ı. Pouzˇity´ model je
zalozˇen na rovnici prˇestupu tepla popisuj´ıc´ı prˇenos tepla mezi na´dorem a okoln´ı zdravou
tka´n´ı. Rovnice byly rˇesˇeny v programu COMSOL Multiphysics metodou konecˇny´ch prvk˚u.
Z vy´sledk˚u vyply´va´, zˇe se na´dory za´sobene´ ze sve´ho povrchu ohrˇ´ıvaj´ı snadneˇji a metodou
mikrovlnne´ hypertermie je mozˇne´ u nich dosa´hnout kompletn´ıho znicˇen´ı. Na´dory, ktery´mi
ce´va procha´z´ı, maj´ı oproti tomu vysˇsˇ´ı na´rok na vy´kon nutny´ k jejich ohrˇa´t´ı na pozˇadovanou
teplotu, cozˇ s sebou nese mozˇnost veˇtsˇ´ıho posˇkozen´ı okoln´ı tka´neˇ.
Kl´ıcˇova´ slova
Mikrovlnna´ hypertermie; numericka´ simulace; ce´vn´ı za´soben´ı na´doru
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1 Introduction
Tumour diseases figure among the leading causes of death worldwide. Development of new
therapies and improvements of existing cancer treatment methods are therefore highly
demanded.
Microwave hyperthermia is a cancer treatment method like surgery, chemotherapy and
radiotherapy. It uses microwaves to heat the tissue in order to destroy the cancer cells.
Its greatest advantages are the use of non-ionizing radiation and the non-invasiveness of
the method. It can be used independently, but best results are delivered in combination
with chemotherapy and radiation therapy.
The use of heat in medicine and cancer treatment is not a completely new concept.
Already in 1866 a German physician Dr. W. Busch reported the disappearance of a facial
sarcoma in a patient suffering from high fevers [1]. Modern hyperthermia uses elevated
temperatures for destroying tumour cells due to the unorganized vascular system of these,
which makes them less resistant to heat. The temperature rise can be achieved by lasers,
ultrasound or microwaves. Along with the temperature the blood circulation and tissue
perfusion increases. This phenomenon is utilized in combination with chemotherapy, in
which the increased perfusion of the tumour can ensure better regional efficacy of the
medication used.
For the clinical use of microwave hyperthermia the treatment planning is crucial. This
is necessary for design, control and evaluation of the treatment. One of the most difficult
problems during treatment planning is the determination of the complete temperature
field in the tumour and also in surrounding healthy tissues. Such determination is very
important for evaluating the treatment efficacy. To be able to compute the complete
temperature distribution, it is possible to use mathematical models and computer simu-
lations. In these numerical simulations it is essential to also consider the possible effect
of larger vessels on the treatment. Large blood vessels can produce localized cooling in
heated tissues during hyperthermia treatment, causing inhomogeneities in the temperature
distribution in the tissue, and thereby a decrease of the treatment efficacy [2].
The computed heat distribution during the hyperthermia treatment should be then
tested on a suitable real object before being applied directly to patients. Agar phan-
toms are very often being used for these purposes, because their material properties and
behaviour during thermotherapy are very similar to those of real human tissue.
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1.1 Microwave thermotherapy
Microwaves are widely used in medicine, both in diagnostic and therapeutic applications.
Treatment methods based on the thermal effect of microwaves are referred to as microwave
thermotherapy. This can be further divided according to the goal temperature or interval
achieved during therapy. Diathermia is heating of tissue to the temperature of 41◦C and
is used for chronic pain and inflammation treatment. Hyperthermia stands for heating
to the goal interval of 41◦C – 45◦C, using the principle of a different biological response
of healthy and tumour tissue and so can be used for cancer treatment. In cancer ther-
apy is hyperthermia often used as an adjunct to chemotherapy and radiation therapy.
An application in urology, used for prostate treatment, is microwave thermocoagulation
(thermoablation), which uses temperatures higher than 45◦C. Among other applications
can be also mentioned microwave scalpel used in surgery and microwave tomography used
for tumour detection based on differences in tissue electrical properties as a representation
from the field of diagnostics.
1.2 Biological effects of microwave energy
Microwaves are a form of electromagnetic radiation with frequencies from 300 MHz to
300 GHz. This corresponds to wavelength in the range between 1 mm and 10 cm. Their
long-term effect on the human organism is still being discussed as the problem is very
complex and the effects are dependent on many factors and circumstances. However, no
long-term effects of microwaves on the organism have been proven yet. Biological effects
of microwave energy can be divided into two main groups: thermal and non-thermal
effects [3].
Thermal effects
Thermal effects of microwaves are caused by absorption of microwave radiation in the irra-
diated tissue. The absorption is dependent on many factors such as frequency, orientation
and polarization of the radiation, electrical and magnetic field intensity and dielectric pa-
rameters of interacting tissues. Those effects are accompanied by physiological responses,
which are dependent on the intensity and duration of the field [3].
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Non-thermal effects
There is no heating of the tissue at a low energy level of the electromagnetic field. No
noxiousness of the non-thermal effects of microwave energy has been proven in studies
conducted in vitro on living cells, but it is still a subject of discussion [3].
The rate of power absorbed in the biological tissue is often expressed using Specific
absorption rate (SAR). This dosimetric parameter is an indicator of energy amount dis-
sipated in the tissue. It is defined as power absorbed per 1 kg of tissue. SAR indicates
the electromagnetic field exposure rate of biological tissue very precisely, but is difficult
to measure. Therefore it is often computed using the Eq. 1,
SAR =
∂
∂t
(
∂W
∂m
)
=
∂
∂t
(
∂W
ρ∂V
)
=
∂P
∂m
=
∂P
ρ∂V
(1)
where W is electromagnetic energy absorbed in biological tissue, t is time, m represents
mass. P stands for the power of electromagnetic wave passing through the biological
tissue, ρ is tissue density and V is the tissue volume.
1.3 Principles of hyperthermia
Hyperthermia is based on the principle of different biological response to heating of healthy
and tumour tissue. Healthy tissue has a reflexive defence mechanism of increasing blood
circulation in order to cool down the heated tissue. This mechanism protects the healthy
tissue from thermal damage up to 45◦C. Several experiments have shown that the tissue
perfusion is temperature dependent. In healthy tissue, when heated up to 45◦C, the blood
flow continuously increases in order to protect the tissue from further heating. On the
contrary, tumour tissue shows a decrease in blood flow when heated and due to irregular
and chaotic vasculature, which hinders the perfusion and enhances further temperature
increase. Tumour tissue is therefore being damaged already at 41◦C. Diameter of blood
vessels can increase in healthy tissue due to the local response which dilates the heated
vessels by relaxing vascular smooth muscles. But neoplastic tumour vasculature lacks this
mechanism due to the lack of smooth muscles [4]. The different temperature curves for
healthy and tumour tissue can be seen in Fig. 1. In all tissues, for temperatures above
45◦C, blood flow decreases due to irreversible damages in the vasculature [5].
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Figure 1: Temperature curves for tumour and healthy tissue with identical heating con-
ditions. Taken from [3], translated.
1.4 Hyperthermia treatment planning
Despite the promising potential of hyperthermia treatment proven in numerous studies,
it has so far failed to gain widespread acceptance. This might be due to the difficulty of
providing reliable heating of the entire tumour while reducing energy absorption in healthy
tissue, caused by complexity of the applicators and no straightforward relationship between
the treatment settings and the resulting temperature distribution. The goal of hyperther-
mia treatment planning is therefore to solve this problem and help to visualize the course
of the treatment [6].
In order to maximize the treatment effectiveness, reliable information about spatial
power distribution and temperature during hyperthermia treatment is essential. One
of the biggest challenges during clinical hyperthermia is the determination of the com-
plete 3D temperature field throughout the treatment area, including both healthy and
tumour tissue. Thus the complex relation between heating, tissue perfusion, vasculature
and anatomical structures needs to be considered. Also blood perfusion plays an impor-
tant role in temperature distribution. Therefore it is important to take vasculature into
consideration during hyperthermia treatment planning. Temperature and power distribu-
tion is usually non-uniform, due to heterogeneous thermal and dielectric tissue properties.
As heat removal by blood flow is also non-uniform, it only contributes to the heterogeneity
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of temperature distribution [7].
Typical frequencies used in microwave hyperthermia treatment are 434 MHz, 915 MHz
and 2450 MHz. The last is used for superficial treatments as it only allows heating to
a depth of 1.5 cm in muscle tissue. Frequency 434 MHz is used for local subsurface
treatments in depths between 2 and 4 cm in muscle tissue [3].
There are several models of various complexity used for the purpose of treatment
planning. The most used model is Penne’s bioheat equation:
ρCp
∂T
∂t
+∇ · (−k∇T ) = Cbωbρb(Tb − T ) +Qmet +Qext, (2)
where Cp is the specific heat capacity of the tissue (J/(kg·K)), k is the tissue thermal
conductivity (W/(m·K)), ρb represents the blood density (kg/m3), Cb is the specific heat
capacity of blood (J/(kg·K)), ωb blood perfusion rate (1/s), Tb represents arterial blood
temperature (K), Qmet is the metabolic heat source (W/m
3) and Qext is an external heat
source (W/m3) [8].
This bioheat equation uses a heat sink proportional to the local temperature rise
and a non-directional volumetric average perfusion rate. Its weakness is that it does not
consider the direction of blood flow. Basic vasculature models are relatively simple with
blood vessels represented as straight tubes of a specified inner diameter. These models
are used to compute temperature distribution during thermal treatment or ablation [7].
More advanced models are in 3D with branching vessel network and provide a more
complex description of the temperature field. In the sophisticated discrete vasculature
(DIVA) model the vessel-network is described by 3D curves with a specified diameter, so
it allows more precise thermal modelling. This model is compatible with MR/CT angiog-
raphy vessel reconstruction software, which is important for routine use in hyperthermia
treatment planning. The DIVA model was validated experimentally by using isolated
perfused animal tissue (tongue) and this comparison showed an excellent agreement [7].
Hyperthermia treatment planning helps to optimize the generated temperature distri-
bution within the patient’s body to a level, where essentially the tumour is heated, but
preferably not any normal tissue is damaged. For this reason, patient-specific treatment
planning is necessary. In order to achieve this, prospective treatment planning is used.
Detailed knowledge of the particular patient’s anatomy is needed in order to be able to
compute the power deposition patterns in the tissue and provide individual patient treat-
ment planning. Prospective hyperthermia treatment planning can noticeably improve the
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effectiveness and quality of the treatment [6, 9].
The electromagnetic field distribution in the patient is calculated by numerically solv-
ing Maxwell equations. Absorbing boundary conditions are essential for the models in
order to avoid reflections of the electromagnetic waves at the boundaries of the computa-
tional domain. In order to obtain the required solutions, it is desirable to use numerical
simulations. Besides a number of commercially available dedicated treatment planning
software packages (i.e. Sigma HyperPlan or Sim4Life), electromagnetic calculations and
thermal simulations for hyperthermia treatment planning can be executed using general
purpose commercial software packages such as COMSOL Multiphysics, Ansys High Fre-
quency Structural Simulator and CST STUDIO SUITE. These software packages provide
flexibility in applicator modelling, but supplementary software is required for tissue seg-
mentation and treatment optimization [9].
1.5 Tumour vasculature
In order to study the temperature distribution in tumour tissue during hyperthermia
treatment, it is necessary to outline the fundamental principles of tumour angiogenesis,
vasculature morphology and its role in hyperthermia.
It is widely accepted that most tumours and metastases originate as small avascular
mass formations that induce the development of new blood vessels once they grow to a
few millimetres (around 2 mm) in size. Initial avascular growth is typical for tumours
that arise in epithelial structures and are separated from the underlying vasculature by a
basement membrane [10] .
Tumour vasculature has abnormal morphology with unstable and devious blood vessels.
This phenomenon can be used in treatments, where tumour blood vessels are targeted in
order to suppress tumour growth. They can be selectively destroyed without affecting
normal blood vessels.
1.6 Angiogenesis
Tumours need blood supply in order to grow. They have to develop their own functional
blood supply from the already established healthy tissue vasculature. The process of new
blood vessels creation from already existing vessels is called angiogenesis. It is initiated by
local hypoxia (decreased availability of oxygen to the body tissues), which activates vas-
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cular endothelial growth factors (VEGFs), that can stimulate endothelial-cell growth [11].
In the absence of angiogenesis, tumour growth is restricted. Therefore tumour dimensions
are limited to a microscopic size of 1-2 mm. At this magnitude simple diffusion of nu-
trients and waste products becomes limiting for continuous development of the tumour.
Such avascular growth is characteristic for tumours separated from the blood vessels by
a membrane, i.e. tumours in early development stage originating in epithelial tissue [12].
Initiation of tumour angiogenesis is signalized by structural destabilization of already
existing blood vessels. Endothelial cells migrate under the influence of VEGFs secreted by
the tumour towards the tumour cells and it comes to creation of new blood vessels. This
process leads to a loss of hierarchic composition of large, middle sized and small blood
vessels as found in the normal vascular system, which is the reason why tumour vessels
have irregular shape and diameter, they are devious, leaky and often have dead ends. The
resulting arrangement of tumour vasculature is therefore insufficient in terms of metabolic
demands of the tissue. Later, tumour blood vessels will go through stabilization and
remodelling process. During this process, the dense network of immature and chaotically
organized blood vessels clumps together and form blood vessels with increased diameter.
This happens in the middle of the tumour and leads to a better arrangement of vasculature
and blood supply in the tumour, but on the contrary also to a local necrosis of the tissue
inside the tumour core [13, 14]. The stabilization process can be seen in Fig. 2.
Figure 2: Blood vessel stabilization in the tumour centre associated with extended necrosis
of tumour tissue. Taken from [13].
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1.7 Tumour blood flow
The tumour neovasculature is not only critical for survival of the tumour cells, but it is
also probably one of the most important factors influencing the therapeutic application of
hyperthermia. As blood flow is one of the major means by which heat can be dissipated
from perfused tissues, the vasculature is a target for hyperthermia damage. Generally,
the lower the rate of blood flow, the easier it is to heat. Therefore sometimes the concept
of vascular targeting agents (VTAs) is being used as a therapeutic approach in order to
disrupt the tumour vasculature and hereby facilitate regional heating.
As the tumour neovasculature has a very different structure from the normal vessels,
it is unable to meet all oxygen and nutrient needs of the growing tumour; therefore some
areas in the tumour mass can become oxygen deprived, nutrient deficient, and highly
acidic. When a neoplastic tissue is heated, lactic acid accumulates and hence, the pH
decreases within the tissue. This decrease in pH increases vascular destruction. Cells
existing in such conditions are then even more sensitive to the cytotoxic action of heat [15].
The blood supply to tumours is spatially heterogeneous, and it decreases, in general, as
the tumour grows larger. Because of blood flow heterogeneities, even the poorly perfused
tumours may have regions of high perfusion rate making it difficult to heat these tumours
effectively [4].
1.8 Thesis aims and objectives
The aim of this thesis is to create multiple numerical simulations describing local mi-
crowave heating of two different tumour types based on their blood supply - tumour,
which lies directly on the blood vessel and tumour being supplied from its surface. Sim-
ulations of electromagnetic field distribution, heat transfer and blood flow for tumours of
three different diameters placed in various depths under the skin will be made in COMSOL
Multiphysics. Furthermore, an agar phantom is to be created and used in an experiment.
The aim of the agar phantom experiment is to validate correct material parameter and
boundary settings in the numerical simulations. Generator output power and water bolus
temperature will be regulated in the numerical simulations. The goal of this regulation
is adjustment of the simulated temperature distribution in the tissue aiming a treatment
outcome optimization.
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2 Methods
Three different numerical simulations of a spherical tumour located in various tissues were
designed. Two models represent tumour, which lies directly on the blood vessel, and tu-
mour being supplied by blood and nutrients from its surface. The third model is a modified
version of tumour lying directly on the blood vessel. This model was used to evaluate re-
sults from measurement on a heterogeneous agar phantom, which consisted of more layers
of agar representing different human body tissues. The agar model was created for the
purpose of experimental validation of settings of the former two computational models.
The model was therefore simplified according to the experimental setup possibilities.
2.1 Experimental setup
Experiment was conducted using a heterogeneous agar phantom consisting of mixture of
tumour, blood vessel, muscle tissue, subcutaneous fat and skin. Vessel was imitated using
a PE tube with inner diameter of 2 mm and wall thickness of 0.5 mm. The rest of tissues
were simulated with agarose and different ingredients.
Tumour phantom
Tumour phantom consists of:
• 100 mL of distilled water
• 60 mL of 96% ethanol
• 4 g of agarose
• 2.9 g of NaCl
• 0.1 g of food colouring
Distilled water, ethanol, salt and food colouring were mixed in a pot and heated. At
a temperature around 80◦C agarose was added to the mixture and everything was stirred
for one minute and then poured in a prepared mold letting it to solidify directly on the
tube representing blood vessel. The final sample as well as the mold can be seen in Fig. 3.
Directions were taken from the article [16] with a slight modification - the agarose
percentage in the mixture was increased after performing some testing samples and in
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accordance with work [17]. This alternation was introduced in order to improve the phan-
tom texture so, that it holds together more and can be used for creating a heterogeneous
phantom.
Figure 3: Prepared tumour phantom on a PE tube (left) and the mold used (right).
Muscle phantom
The agarose mixture representing muscle tissue contained:
• 2800 mL of water
• 9.7 g of NaCl
• 117 g of agarose
All ingredients were mixed together and heated until the final mixture started to
abruptly change its density. Then the mixture was poured into a mold letting the mixture
to solidify. Directions were taken from [17], only tap water was used instead of deionized
water. Measured dielectric properties of the phandom made of deionized or tap water did
not show any difference.
Fat phantom
Layer representing subcutaneous fat consisted of:
• 134 g of wheat flour
• 60 g of sunflower oil
• 5.94 g distilled water
• 0.06 g of NaCl
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All ingredients were mixed in a bowl and the resulting dough was kneaded until it was
elastic and smooth on the outside. Then the dough was spread in a thin layer on the
already solidified agar muscle phantom. Directions were taken from [17].
Composition of the skin phantom was the same as for the muscle phantom, as skin
and muscle tissues have very similar dielectric parameters. Agarose mixture representing
skin was then poured at the top of the fat layer. The final heterogeneous agar phantom
can be seen on Fig. 4.
Figure 4: Prepared heterogeneous agar phantom; a cross section.
A sample was taken from each component of the heterogeneous phantom and its dielec-
tric parameters were measured (Fig. 5) to be used later in the numerical simulation. This
measurement was performed using DAK-12 coaxial dielectric probe (Schmid & Partner
Engineering AG) connected to KEYSIGHT FieldFox N9923A vector network analyzer.
Dielectric parameters were measured in the 10 MHz – 3 GHz frequency range. Results of
measurements for the complete frequency range can be found in Attachment n. 1 . For
the simulations were used dielectric parameters measured on the frequency of 434 MHz.
The experimental setup consisted of the heterogeneous agar model, peristaltic pump
FH100 from Thermo Scientific, two reservoir bottles, silicone tubing with connectors at-
taching the tube inside the phantom to the rest of the tubing and a wave generator with
rectangular waveguide applicator with aperture dimensions 7.5×10 cm. Scheme of the
experimental setup is presented in Fig. 6. The final thermographic picture was taken by
thermographic camera FLIR E60 (FLIR Systems AB, Eskilstuna, Sweden).
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Figure 5: Experimental setup during measurement of dielectric parameters with coaxial
dielectric probe and vector network analyzer.
Experiment was performed after temperature stabilization of all model components at
23◦C, as it was not possible to keep all components tempered at body temperature. Blood
was replaced by saline (9 g of salt per 1 L of water) for experimental purposes and pumped
by a peristaltic pump set to 400 RPM through the circuit. This setting provided saline
flow of 1 cm/s, which was calculated using the pump datasheet and verified experimentally.
The output power of the microwave generator was set to 100 W and exposition time was
two minutes. After this time, applicator was removed, agar phantom was placed under a
thermographic camera, cut in half along the vessel and opened and thermographic images
of the cross section were taken. This procedure needed to be performed as quickly as
possible in order to minimize heat loss.
Figure 6: Scheme of the experimental setup.
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2.2 Simplified numerical model
The simplified model used for evaluating the measurement outcome is an exact copy of
the agar model created for the experiment. The numerical and agar models are identical
in their dimensions and composition. Previously measured dielectric parameters of the
different agar layers were also used as input in the numerical model in order to simulate
the performed measurement as accurately as possible. The numerical model therefore
consists of homogeneous muscle tissue of 10 cm height, a spherical tumour (d=2 cm)
placed directly on a blood vessel (i.d. 2 mm) with its centre 2.7 cm under the surface,
8 mm layer of subcutaneous fat and 4.5 mm of skin. The base diameter of the cylindrical
model is 20 cm and its thermophysical properties are presented in Table 1. Relative
permittivity and electric conductivity of the agar mixtures used were measured and rest
of the values were used from literature. The complete model can be seen on Fig. 7 and its
individual parts are visualized in Fig. 9.
Figure 7: Cylindrical model with base diameter of 20 cm used for the simulations with
4.5 mm skin, 8 mm fat, and 10 cm muscle thicknesses. Vessel inner diameter is 2 mm with
1 mm wall thickness. Waveguide aperture dimensions are 10×7.5×3 cm.
The electrical field, blood flow velocity and temperature distribution were computed
using Multiphysics (COMSOL AB, Stockholm, Sweden) – a finite element software. Three
different computational modules were used in order to solve the combined bioheat transfer
– Electromagnetic Waves, Laminar Flow and Bioheat Transfer. As temperature depen-
dence of tissue parameters was not included in the final simulations, individual study steps
could be separated and computed successively.
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Figure 8: Resulting mesh of simplified computational model in x-z plane
Table 1: Thermal, biological and dielectric properties of phantom materials at 434 MHz
and 23◦C.
σ ( Sm) ρ (
kg
m3
) k ( Wm·K)  (–) ωb (
1
s ) Cp (
J
kg·K)
Muscle 0.72 1090 [18] 0.49 [18] 75.5 6 · 10−3 [5] 4200 [19]
Vessel Wall 10−15 [20] 940 [21] 0.33 [20] 2.3 2.27 · 10−4 [5] 1900 [20]
Blood 1.85 1000 [18] 0.61[22] 77.3 – 3617[18]
Fat 0.03 911 [18] 0.21 [18] 4.96 5.98 · 10−5 [5] 2348 [18]
Skin 0.75 1109 [18] 0.37 [18] 73.5 1.6 · 10−3 [5] 4200 [19]
Tumour 1.45 1040 [23] 0.64 [18] 59.5 7.93 · 10−4[5] 4200 [19]
Electromagnetic Waves and Laminar Flow were computed using a stationary study,
whereas for Bioheat Transfer a Frequency-Transient study was used. The Frequency-
Transient study duration was set to 2 minutes in order to match the experiment condi-
tions. Power output of the wave generator was 100 W. The model was meshed with Free
tetrahedral mesh set to Finer with minimal element size of 0.081 cm and maximal element
size of 1.11 cm. Complete mesh consisted of 221069 elements. The resulting mesh can be
seen in Fig. 8.
Temperature of all components of the numerical model was set to 23◦C in order to
match with the temperature during the experiment. Blood flow in the vessel was defined
by inflow and outflow velocity – 1 cm/s.
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(a) Muscle (b) Applicator
(c) Skin (d) Fat
(e) Tumour (f) Blood vessel
Figure 9: A visualisation of all components of the simplified numerical model.
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2.3 Numerical model – tumour lying on a blood vessel
Multi-layer model representing tumour lying directly on a blood vessel consisted of 10 cm
of muscle tissue, fat layer of 6 mm, 2 mm of skin, blood vessel with 5 mm i.d. and 1 mm
wall thickness, tumour, microwave applicator and 1 cm of water bolus. Water bolus serves
for cooling hotspots arising at the skin surface in contact with the microwave applicator.
The resulting model can be seen in Fig. 10. Tumour size and its position under model
surface varied; tumour diameters of 1 cm, 1.3 cm and 1.5 cm placed on a vessel in depths of
1.8 cm, 2 cm and 2.5 cm under the skin were used for the simulation. Depth of the tumour
under the skin surface is always expressed for the centre of the tumour. Lateral dimensions
of the model are 15×15 cm and waveguide aperture dimensions are 7.5×10×1 cm. All
parts of the model are separately displayed in Fig. 12.
Figure 10: Model with blood vessel used for the simulations with 2 mm skin, 6 mm fat,
1 cm of water bolus and 10 cm muscle thickness. Lateral dimensions are 15×15 cm.
Waveguide aperture dimensions are are 7.5×10×1 cm.
Temperature of all body tissues in the model was set to 37◦C and the cooling bolus
was embodied in a boundary condition with fixed Tbolus = 18
◦C. Blood flow velocity was
set to 6 cm/s. All thermal and dielectric properties used in the simulation are displayed
in Table 2.
Results were again obtained in COMSOL Multiphysics using successive simulations
of Electromagnetic Waves, Laminar Flow and Bioheat Transfer. The model was meshed
with Free tetrahedral mesh set to Finer with minimal element size of 0.06 cm and maximal
element size of 0.83 cm. The resulting mesh can be seen in Fig. 11.
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Table 2: Thermal, biological and dielectric properties of body tissues used in model at
434 MHz and 37◦C.
σ ( Sm) ρ (
kg
m3
) k ( Wm·K)  (–) ωb (
1
s ) Cp (
J
kg·K)
Muscle 0.81 [18] 1090 [18] 0.49 [18] 56.9 [18] 6 · 10−3 [5] 3421 [18]
Vessel Wall 0.57 [18] 1102 [18] 0.46 [18] 46.7 [18] 2.3 · 10−4 [5] 3306 [18]
Blood 1.36 [18] 1050 [18] 0.52[18] 36.8 [18] – 3617[18]
Fat 0.08 [18] 911 [18] 0.21 [18] 11.6 [18] 6 · 10−5 [5] 2348 [18]
Skin 0.70 [18] 1109 [18] 0.37 [18] 46.1 [18] 1.6 · 10−3 [5] 3391 [18]
Tumour 0.85 [23] 1040 [23] 0.51 [23] 57.9 [23] 7.9 · 10−4[5] 3950 [23]
Figure 11: Resulting mesh of model of tumour lying directly on a blood vessel in x-z plane
All simulations were performed for an operating frequency of 434 MHz using station-
ary studies. Output power absorbed in the tissue together with temperature of water
bolus were tuned aiming to ensure temperature distribution destroying the tumour tissue
completely while causing the lowest possible damage to surrounding healthy tissue.
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(a) Applicator (b) Water bolus
(c) Skin (d) Fat
(e) Tumour (f) Blood vessel
(g) Muscle
Figure 12: A visualisation of all components of the numerical model of tumour being
placed directly on a blood vessel.
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2.4 Numerical model – tumour supplied from its surface
Numerical model of tumour being supplied by blood and other nutrients from its surface
stands for a situation after vascular remodelling process causing local necrosis of the tissue
inside the tumour. Model consists of 10 cm of muscle tissue, subcutaneous fat of 6 mm,
2 mm of skin, 1 cm of water bolus and tumour composed of two spheres. Outer sphere is
well-perfused tumour tissue while inner sphere is necrotic with very low blood perfusion
rate. Outer dimensions of this model as well as waveguide applicator size are the same as
in the previous model. The entire model is displayed in Fig. 13 and its components are
presented separately in Fig. 14. Tumour sizes and positions under the skin used in the
simulations were the same as in model with tumour lying on a blood vessel. Therefore
diameters of 1 cm, 1.3 cm and 1.5 cm with their centre placed in depths of 1.8 cm, 2 cm
and 2.5 cm under the skin were studied in parametric simulations performed in COMSOL
Multiphysics. As the tumour model consisted of two spheres, the core diameter was always
adjusted according to the tumour diameter. Table 3 presents the core diameters matching
to different tumour sizes used.
Figure 13: Model used for the simulations with 2 mm skin, 6 mm fat, 1 cm of water
bolus and 10 cm muscle thickness. Lateral dimensions are 15×15 cm. Waveguide aperture
dimensions are 7.5×10×1 cm.
Table 3: Diameters of tumour cores dependent on tumour diameters in the simulation.
Tumour diameter (mm) Core diameter (mm)
10 4
13 5
15 6
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Table 4: Thermal, biological and dielectric properties of body tissues used in model at
434 MHz and 37◦C.
σ ( Sm) ρ (
kg
m3
) k ( Wm·K)  (–) ωb (
1
s ) Cp (
J
kg·K)
Muscle 0.81 [18] 1090 [18] 0.49 [18] 56.9 [18] 6 · 10−3 [5] 3421 [18]
Fat 0.08 [18] 911 [18] 0.21 [18] 11.6 [18] 6 · 10−5 [5] 2348 [18]
Skin 0.70 [18] 1109 [18] 0.37 [18] 46.1 [18] 1.6 · 10−3 [5] 3391 [18]
Tumour perfused 0.85 [23] 1040 [23] 0.51 [23] 57.9 [23] 7.9 · 10−4[5] 3950 [23]
Tumour necrotic 0.89 1040 [23] 0.51 [23] 50 7.9 · 10−5 3950 [23]
The model was meshed with Free tetrahedral mesh set to Finer with minimal ele-
ment size of 0.06 cm and maximal element size of 0.83 cm. The resulting mesh can be
seen in Fig. 15. Stationary studies of Electromagnetic Waves and Bioheat Transfer for
an operating frequency of 434 MHz were performed.
Boundary conditions and temperature settings were identical to the previous model
and all thermal and dielectric properties of the simulated tissues are summarized in Ta-
ble 4. Blood flow velocity through the blood vessel was 6 cm/s. Settings of water bolus
temperature and output power absorbed in the tissue were manually tuned in order to
obtain the desired temperature distribution. The aim of this setting was to maximize tu-
mour volume heated to temperature above 41◦C together with minimizing tissue volume
heated to more than 45◦C.
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(a) Applicator (b) Water bolus
(c) Skin (d) Fat
(e) Perfused tumour (f) Necrotic tissue
(g) Muscle
Figure 14: A visualisation of all components of the numerical model of tumour being
supplied from its surface.
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Figure 15: Resulting mesh of model of tumour being supplied from its surface in x-z plane.
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3 Results
Experimental results as well as results of conducted numerical simulations are presented in
this chapter. First, results from agar phantom experiment used for validating parameter
settings in following simulations are presented and compared with results obtained from
the matching simplified simulation. Further, results from simulations of both tumour
types studied are introduced. For all simulations, graphical results of electromagnetic
power loss density and temperature field distribution are displayed. Results are displayed
in a vertical slice in the centre of the model. Colour range was manually unified in
COMSOL Multiphysics, aiming the results to be mutually visually comparable. Result
displaying blood flow in a vessel is presented only once (in Fig. 19) as the velocity profile
was identical in all simulations. Tumour volume heated to temperature T>41◦C, volume of
surrounding tissue heated to more than 45◦C as well as microwave generator power output
and bolus temperature settings needed to achieve the presented temperature distribution
are summarized in Tables 5 - 13.
3.1 Experimental validation of the numerical model
The temperature field distribution in the agar model cross section after application of
microwaves over 2 minutes can be seen in Fig. 16. Tumour position was marked within
the picture for better distinction.
Figure 16: Thermographic image of agar phantom after microwave heating with marked
tumour position, a cross section.
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Outcome of the numerical simulation using parameters of the agar model is presented
in Fig. 17. In Fig. 18, outcome of the numerical simulation with highlighted isothermal
contours is displayed. Contours are figured in steps of 1◦C. This figure serves for better
comparison of the temperature field shapes in experiment and simulation.
Figure 17: Simulated temperature distribution in model representing agar phantom,
a cross sectional slice in y-z plane.
Figure 18: Simulated temperature distribution in model representing agar phantom with
isothermal contours displayed, a cross sectional slice in y-z plane. Temperature of the
contours is displayed in blue colour.
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3.2 Tumour lying on a blood vessel
Results obtained from model of tumour lying on a blood vessel are presented in Tables 5 –
7 and Fig. 20 – 25. Each table contains results for one tumour depth (1.8, 2, or 2.5 cm)
and all three tumour diameters (1, 1.3 and 1.5 cm). Volume of tumour heated to temper-
ature higher than 41◦C is displayed as well as volume of healthy tissue surrounding the
tumour which might be damaged with temperature exceeding 45◦C. Also output power
and water bolus temperature settings are displayed in the tables. Colour range of tem-
perature results was unified to 7− 52◦C and range of electromagnetic power loss density
to 0− 9 · 105 W/m3.
Result of blood flow distribution in a vessel is presented only once in Fig. 19, as the
velocity profile was identical in all simulations including blood vessel.
Figure 19: Velocity profile of blood stream through the model, close up of a cross sectional
slice in y-z plane.
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Table 5: Simulation results for tumour lying 1.8 cm under skin surface.
Tumour volume
(cm3)
Tumour volume,
T>41◦C (cm3)
Surrounding tissue,
T>45◦C (cm3)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 0.5 0.5 11.6 58 10
d=1.3 cm 1.2 1.2 10.2 57 10
d=1.5 cm 1.8 1.8 9.8 56 10
(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 20: Temperature distribution in tumours lying on a blood vessel in depth of 1.8 cm,
a cross sectional slice in y-z plane.
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(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 21: Electromagnetic power loss density in tumours lying on a blood vessel in depth
of 1.8 cm, a cross sectional slice in y-z plane.
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Table 6: Simulation results for tumour lying 2 cm under skin surface.
Tumour volume
(cm3)
Tumour volume,
T>41◦C (cm3)
Surrounding tissue,
T>45◦C (cm3)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 0.5 0.5 16.8 61 10
d=1.3 cm 1.2 1.2 15.8 59 12
d=1.5 cm 1.8 1.8 14.5 59 10
(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 22: Temperature distribution in tumours lying on a blood vessel in depth of 2 cm,
a cross sectional slice in y-z plane.
38
(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 23: Electromagnetic power loss density in tumours lying on a blood vessel in depth
of 2 cm, a cross sectional slice in y-z plane.
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Table 7: Simulation results for tumour lying 2.5 cm under skin surface.
Tumour volume
(cm3)
Tumour volume,
T>41◦C (cm3)
Surrounding tissue,
T>45◦C (cm3)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 0.5 0.5 34.7 71 7
d=1.3 cm 1.2 1.2 34.5 70 10
d=1.5 cm 1.8 1.8 33.5 68 12
(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 24: Temperature distribution in tumours lying on a blood vessel in depth of 2.5 cm,
a cross sectional slice in y-z plane.
40
(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 25: Electromagnetic power loss density in tumours lying on a blood vessel in depth
of 2.5 cm, a cross sectional slice in y-z plane.
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As it was not possible to heat the complete tumour volume to the desired tempera-
ture above 41◦C without overheating some surrounding tissue, another set of results was
created. Tables 8 – 10 present the percentage of tumour tissue, which could be heated
to more than 41◦C without damaging any surrounding tissue. Output power and water
bolus temperature settings used to obtain these results are presented in the tables as well.
Table 8: Simulation results for tumour lying 1.8 cm under skin surface, without surround-
ing tissue damage.
Tumour percentage,
41◦C>T>45◦C (%)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 99.2 47 10
d=1.3 cm 99.6 45 10
d=1.5 cm 99.7 43 10
Table 9: Simulation results for tumour lying 2 cm under skin surface, without surrounding
tissue damage.
Tumour percentage,
41◦C>T>45◦C (%)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 98.9 48 10
d=1.3 cm 99.2 45 12
d=1.5 cm 99.4 42 10
Table 10: Simulation results for tumour lying 2.5 cm under skin surface, without sur-
rounding tissue damage.
Tumour percentage,
41◦C>T>45◦C (%)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 95.1 49 7
d=1.3 cm 97.2 46 10
d=1.5 cm 98.2 44 12
42
3.3 Tumour being supplied from its surface
In Fig. 26 – 31, temperature and electromagnetic power loss density distributions in
tumour being supplied from its surface are presented. The value of depth under skin
surface is always related to the centre of the tumour. Electromagnetic power loss density
colour range was manually adjusted for all results to 0− 5 · 105 W/m3 and temperature
range to 7− 48◦C. These adjustments were made with the aim of easier visual comparison
of the results. Output power needed for complete tumour destruction is mainly increasing
with tumour diameter and depth under skin surface as displayed in Tables 11 – 13. It
was possible to heat the complete tumour volume to the desired temperature above 41◦C
without overheating any surrounding tissue in all simulations of tumour being supplied
from its surface.
Table 11: Simulation results for tumour lying 1.8 cm under skin surface.
Tumour volume
(cm3)
Tumour volume,
T>41◦C (cm3)
Surrounding tissue,
T>45◦C (cm3)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 0.5 0.5 0 27 13
d=1.3 cm 1.2 1.2 0 27 12
d=1.5 cm 1.8 1.8 0 27 12
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(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 26: Temperature distribution in tumours being supplied from their surface in depth
of 1.8 cm, a cross sectional slice in y-z plane.
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(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 27: Electromagnetic power loss density in tumours being supplied from their surface
in depth of 1.8 cm, a cross sectional slice in y-z plane.
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Table 12: Simulation results for tumour lying 2 cm under skin surface.
Tumour volume
(cm3)
Tumour volume,
T>41◦C (cm3)
Surrounding tissue,
T>45◦C (cm3)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 0.5 0.5 0 28 13
d=1.3 cm 1.2 1.2 0 29 13
d=1.5 cm 1.8 1.8 0 30 12
(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 28: Temperature distribution in tumours being supplied from their surface in depth
of 2 cm, a cross sectional slice in y-z plane.
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(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 29: Electromagnetic power loss density in tumours lying being supplied from their
surface in depth of 2 cm, a cross sectional slice in y-z plane.
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Table 13: Simulation results for tumour lying 2.5 cm under skin surface.
Tumour volume
(cm3)
Tumour volume,
T>41◦C (cm3)
Surrounding tissue,
T>45◦C (cm3)
Output power
(W)
Bolus temperature
(◦C)
d=1.0 cm 0.5 0.5 0 28 13
d=1.3 cm 1.2 1.2 0 35 11
d=1.5 cm 1.8 1.8 0 36 10
(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 30: Temperature distribution in tumours being supplied from their surface in depth
of 2.5 cm, a cross sectional slice in y-z plane.
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(a) d=1 cm
(b) d=1.3 cm
(c) d=1.5 cm
Figure 31: Electromagnetic power loss density in tumours being supplied from their surface
in depth of 2.5 cm, a cross sectional slice in y-z plane.
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4 Discussion
Major finding of this master’s thesis is that there is a difference in temperature distribution
after microwave heating of tumours with various blood supply. Results presented in the
previous chapter illustrate the cooling effect of a blood vessel passing through a tumour.
When compared with tumour supplied from its surface, it is also visible how the presence
of blood vessel makes the therapy more demanding in terms of output power needed to
destroy the tumour completely.
In order to be able to evaluate the simulated heating of tumour surrounded by healthy
tissue it was necessary to use a heterogeneous model consisting of different layers repre-
senting various human body tissues. As the experimental validation of the simulations
would not be possible using only a homogeneous model, a heterogeneous agar phantom
was created.
When designing the agar model, it was crucial to find a suitable composition of all
components in the model to imitate dielectric properties of real human body tissues. Some
recipes found in literature turned out not to be suitable and had to be modified. Agar
portion in the mixture representing tumour tissue was considerably increased in order to
improve its consistency for the purpose of this experiment. After this adjustment, the
final mixture was able to hold onto the PE tube, keep its round shape and was not being
dissolved by the following agar mixture being poured over it. It was also found that
there was no difference between dielectric parameters of mixtures created using distilled
water and tap water. As all of the agar model components were drying out quickly, it
was necessary to create the model on the instant to minimize the water loss. Model
was covered with an impermeable cling film during time needed for each layer to solidify
and also during transportation to the place of measurement. However, the measurement
needed to be performed within a few hours after the model formation was complete. Model
dimensions were designed large enough to let the microwaves be attenuated completely
within the agar mass. This prevented reflections at boundaries and possible interference
of reflected waves in the model.
Result of the experiment is presented in Fig. 16. As it was not possible to perform the
experiment at body temperature (37◦C), it was performed at room temperature (23◦C)
and initial conditions in the matching simulation were then adjusted accordingly. After
application of microwaves on the agar model, it was necessary to take a thermographic
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picture of a cross section. The model was therefore cut in half with a knife and a picture
with thermographic camera was taken. As this process took us nearly 90 seconds, some
heat was lost during the process. This explains the temperature difference between ex-
periment and simulation outcome. As the shape of the temperature distribution is for the
purpose of simulation validation more relevant than the maximal temperature, the origi-
nal simulation outcome (Fig. 17) was also displayed with highlighted isothermal contours
(Fig. 18). The isothermal contours in the figure were used for purposes of comparison
with the experimental outcome. Compared, temperature distribution in the simplified
simulation is analogous to the temperature distribution of the simulation outcome. Based
on this we can consider simulation settings validated.
Simulations results of tumour lying directly on a blood vessel show that it was not
possible to heat the studied tumours completely without damaging any surrounding tissue.
In order to heat the complete tumour volume to temperature above 41◦C, it was inevitable
to have also regions of healthy tissue being heated to more than 45◦C. Such temperature
could lead to tissue ablation. However, in real human tissue, the tissue overheating would
be smaller due to temperature dependent tissue perfusion. The temperature dependent
vasodilatation mechanism was not considered in numerical simulations performed.
From presented results can be seen that microwave generator output power needed
for complete destruction of tumour lying on a blood vessel is increasing together with
decreasing tumour diameter. Also volume of overheated surrounding tissue increases as
tumour diameter decreases. This phenomenon can be explained by the fact, that blood
vessel diameter was the same for all tumour diameters used. As images of temperature
distribution visualize, the cooling effect of blood flowing through the tumour applies only
to close proximity of the vessel, as the same vessel diameter was used for all simulated
tumour sizes. This implies, that the smaller the tumour diameter compared to the blood
vessel diameter is, the bigger volume of it is being cooled during the therapy. Therefore
more output power needs to be generated in order to heat the complete tumour volume to
temperature above 41◦C. The increased power output then causes unwanted overheating
of healthy tissue surrounding the tumour.
The coolest place in the heated tissue was in all simulations an area at the vessel
entrance to the tumour. This area shows therefore a high risk of not being destroyed
completely during microwave hyperthermia treatment and causing later a potential tumour
re-growth. As already mentioned, microwave hyperthermia treatment is usually being
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combined with radiotherapy. Therefore it is possible to target this cooler area with a
higher radiation dose. This approach should ensure complete tumour destruction and
decrease the risk of a potential tumour re-growth.
As already stated, the presence of blood vessel in the tumour caused that it was not
possible to destroy the tumour completely without causing any damage to healthy tissue.
Therefore another set of simulations was performed. Their aim was to determine how
much of the tumour tissue can be heated to more than 41◦C without damaging any healthy
tissue. The results presented in Tables 8 – 10 show that also here it was more difficult
to heat small tumours. Percentage of tumour volume heated to desired temperature was
increasing along with tumour diameter. It was also shown that with increasing depth
of the tumour centre under skin surface the percentage of tumour heated to more than
41◦C without healthy tissue overheating was decreasing. Although none of the simulated
tumours lying on a blood vessel was destroyed completely, tumours in depth of 1.8 cm
were heated of more than 99 %.
Simulation results of tumour being supplied from its surface indicate that the deeper
the tumour is seated, the more output power was needed to heat it to desired temperature.
This corresponds with the fact that microwaves are attenuated in the tissue, therefore more
output power is required to penetrate deeper under the surface. In all simulations without
blood vessel it was possible to achieve complete tumour heating to temperatures above
41◦C without causing any damage to surrounding tissue.
When comparing both tumour types, it is visible that blood vessel passing through
a tumour causes local cooling and generally worsens the temperature distribution. It also
causes incomplete tumour heating and could therefore lead to later tumour re-growth.
Compared to that, necrotic core in tumour being supplied from its surface did not create
hot spots or cause any inhomogeneity in the temperature distribution.
Both simulations could be improved in the future by adding temperature dependency
of tissue perfusion to the numerical models. This would refine the results for clinical use in
patient-tailored hyperthermia treatment plan with high probability of tumour destruction
and low risk of healthy tissue damage.
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5 Conclusions
Two numerical models examining local microwave heating of different tumour types based
on their blood supply were developed. They were successfully verified using an assembled
experiment with an agar phantom. Differences in temperature distribution in both simula-
tions during microwave hyperthermia treatment were found. We can say that blood vessel
passing through a tumour has a considerable cooling effect and changes the temperature
distribution in the treated area. It was shown that the presence of blood vessel makes the
therapy more demanding in terms of output power needed to destroy the tumour com-
pletely. It was also found that necrotic core of tumour being supplied from its surface
does not create any hot spots during therapy.
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Figure A1: Measured conductivity of agar mixture representing muscle tissue with ex-
panded measurement uncertainity (coverage factor k=2 ) figured.
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Figure A2: Measured permittivity of agar mixture representing muscle tissue with ex-
panded measurement uncertainity (coverage factor k=2 ) figured.
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Figure A3: Measured conductivity of agar mixture representing tumour tissue with ex-
panded measurement uncertainity (coverage factor k=2 ) figured.
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Figure A4: Measured permittivity of agar mixture representing tumour tissue with ex-
panded measurement uncertainity (coverage factor k=2 ) figured.
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Figure A5: Measured conductivity of agar mixture representing skin with expanded mea-
surement uncertainity (coverage factor k=2 ) figured.
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Figure A6: Measured permittivity of agar mixture representing skin with expanded mea-
surement uncertainity (coverage factor k=2 ) figured.
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Figure A7: Measured conductivity of mixture representing subcutaneous fat with ex-
panded measurement uncertainity (coverage factor k=2 ) figured.
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Figure A8: Measured permittivity of mixture representing subcutaneous fat with expanded
measurement uncertainity (coverage factor k=2 ) figured.
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Figure A9: Measured conductivity of saline representing bloodwith expanded measure-
ment uncertainity (coverage factor k=2 ) figured.
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Figure A10: Measured permittivity of saline representing blood with expanded measure-
ment uncertainity (coverage factor k=2 ) figured.
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